Work With Us

Where We Work (Global Footprint)

  • Home
  • /
  • Services Details

A multi-hub, multi-continent access network.

Immuna operates through a global lattice of hubs and spokes, enabling local delivery of advanced therapies.

  • Europe – Science & Governance Anchor
  • 🇨🇭 Switzerland — Basel & Geneva
  • Translational R&D and clinical collaborations
  • Swissmedic anchoring and regulatory bridging into EU and global markets
  • Global quality, ethics, governance and compliance
  • Corporate headquarters and international partner management
  • South Asia – High-Volume Clinical Triangle
  • 🇮🇳 India — Kerala, Andhra Pradesh, Telangana
  • Southeast Asia – ASEAN Innovation Hub
  • 🇮🇩 Indonesia — Jakarta & Bali
  • Middle East – GCC Logistics & Financing
  • 🇦🇪 Dubai, UAE
  • Gateway for GCC markets
  • Logistics hub for vectors, reagents and equipment
  • Europe – Science & Governance Anchor
  • 🇨🇭 Switzerland — Basel & Geneva
  • Translational R&D and clinical collaborations
  • Swissmedic anchoring and regulatory bridging into EU and global markets
  • Global quality, ethics, governance and compliance
  • Corporate headquarters and international partner management
  • South Asia – High-Volume Clinical Triangle
  • 🇮🇳 India — Kerala, Andhra Pradesh, Telangana
  • Southeast Asia – ASEAN Innovation Hub
  • 🇮🇩 Indonesia — Jakarta & Bali
  • Africa – Pan-African CGT Network
  • 🇰🇪 Nairobi, Kenya (East Africa Hub)
  • Oncology and HIV clinical research capacity
  • First African Immuna GMP and training centre
  • Regional partner hospitals for early-access programs
  • Central Asia – Emerging CGT Frontier
  • 🇰🇿 Kazakhstan — Almaty & Astana
  • Demonstration site for Central Asia’s first decentralized cell therapy program
  • Government-supported biotech corridors
  • Training node for neighbouring countries
  • Africa – Pan-African CGT Network
  • 🇰🇪 Nairobi, Kenya (East Africa Hub)
  • Oncology and HIV clinical research capacity
  • First African Immuna GMP and training centre
  • 🇪🇹 Addis Ababa, Ethiopia (Horn of Africa Node)
  • Strong academic and public health ecosystem
  • High burden of sickle cell disease and thalassemia
  • 🇳🇬 Abuja, Nigeria (West Africa Hub)
  • Federal capital and health policy centre
  • One of the world’s largest sickle cell disease populations
  • Priority site for gene therapy and TriCAR-T adoption
  • Middle East – GCC Logistics & Financing
  • 🇦🇪 Dubai, UAE
  • Gateway for GCC markets
  • Logistics hub for vectors, reagents and equipment
  • Regional partner hospitals for early-access programs
  • Central Asia – Emerging CGT Frontier
  • 🇰🇿 Kazakhstan — Almaty & Astana
  • Demonstration site for Central Asia’s first decentralized cell therapy program
  • Government-supported biotech corridors
  • Training node for neighbouring countries
  • Caribbean – CARICOM
  • 🇬🇾 Guyana — Georgetown
  • Enables cooperation across CARICOM states
  • Mirrors the “national reference facility plus regional network” approach used successfully in other regions
  • 🇪🇹 Addis Ababa, Ethiopia (Horn of Africa Node)
  • Strong academic and public health ecosystem
  • High burden of sickle cell disease and thalassemia
  • 🇳🇬 Abuja, Nigeria (West Africa Hub)
  • Federal capital and health policy centre
  • One of the world’s largest sickle cell disease populations
  • Priority site for gene therapy and TriCAR-T adoption
  • Caribbean – CARICOM
  • 🇬🇾 Guyana — Georgetown
  • Enables cooperation across CARICOM states
  • Mirrors the “national reference facility plus regional network” approach used successfully in other regions